Purpose: We investigated urologist perceptions of barriers to implementing evidence-based medicine in clinical practice.

Materials And Methods: In April 2005 an Internet survey was conducted to assess American Urological Association member attitudes toward evidence-based medicine. This analysis presents the responses to an open-ended question about perceived barriers to implementing evidence-based clinical practice in urology. Two raters developed a coding scheme with 5 main categories of evidence concerns, system level factors, physician factors, patient factors and other barriers. Each rater independently assigned a category to each response. Discrepancies were resolved by consensus.

Results: A total of 365 participants (72%) responded to the open-ended question, each providing up to 4 codable responses. Of the group 53% cited concerns about the evidence including the lack thereof, low quality, limited applicability and biased presentation. In addition, 37% reported system level factors such as issues of reimbursement, fear of litigation, problems with implementation, interference/bias by third parties, and expectations and attitudes of other providers as important issues. Physician factors and patient factors were further cited by 28% and 9%, respectively. In terms of the legitimacy of evidence-based medicine 9% expressed skepticism whereas 5% of respondents indicated that they saw no barriers to implementing evidence-based medicine in urology.

Conclusions: Efforts to promote evidence-based medicine in urology should focus not only on the generation of high quality clinical research but also on its unbiased reporting and timely dissemination. Concerted efforts should be made to reduce system level factors that hinder the implementation of evidence-based care.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2008.01.109DOI Listing

Publication Analysis

Top Keywords

evidence-based medicine
20
barriers implementing
12
implementing evidence-based
12
system level
12
level factors
12
evidence-based
8
open-ended question
8
physician factors
8
factors patient
8
patient factors
8

Similar Publications

Objective: Ankle osteoarthritis is a debilitating condition that significantly impairs patients' quality of life. Platelet-rich plasma has emerged as a novel cellular therapy in clinical practice. This study evaluates the clinical efficacy of platelet-rich plasma (PRP) after intervention in ankle disorders, so as to provide strong evidence in support of clinical treatment.

View Article and Find Full Text PDF

Interpretation and classification of FBN1 variants associated with Marfan syndrome: consensus recommendations from the Clinical Genome Resource's FBN1 variant curation expert panel.

Genome Med

December 2024

European Reference Network for Rare Multisystemic Vascular Disease (VASCERN), HTAD and MSA Rare Disease, Working Group, Paris, France.

Background: In 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) developed standardized variant curation guidelines for Mendelian disorders. Although these guidelines have been widely adopted, they are not gene- or disease-specific. To mitigate classification discrepancies, the Clinical Genome Resource FBN1 variant curation expert panel (VCEP) was established in 2018 to develop adaptations to the ACMG/AMP criteria for FBN1 in association with Marfan syndrome.

View Article and Find Full Text PDF

Background: We sought consensus among practising respiratory physicians on the prediction, identification and monitoring of progression in patients with fibrosing interstitial lung disease (ILD) using a modified Delphi process.

Methods: Following a literature review, statements on the prediction, identification and monitoring of progression of ILD were developed by a panel of physicians with specialist expertise. Practising respiratory physicians were sent a survey asking them to indicate their level of agreement with these statements on a binary scale or 7-point Likert scale (- 3 to 3), or to select answers from a list.

View Article and Find Full Text PDF

Obstructive sleep apnea (OSA) is widespread, under-recognized, and under-treated, impacting the health and quality of life for millions. The current gold standard for sleep apnea testing is based on the in-lab sleep study, which is costly, cumbersome, not readily available and represents a well-known roadblock to managing this huge societal burden. Assessment of neuromuscular function involved in the upper airway using electromyography (EMG) has shown potential to characterize and diagnose sleep apnea, while the development of transmembranous electromyography (tmEMG), a painless surface probe, has made this opportunity practical and highly feasible.

View Article and Find Full Text PDF

Background: Patient-derived organoids (PDOs) represent a promising approach for replicating the characteristics of original tumors and facilitating drug testing for personalized treatments across diverse cancer types. However, clinical evidence regarding their application to esophageal cancer remains limited. This study aims to evaluate the efficacy of implementing PDOs in clinical practice to benefit patients with esophageal squamous cell carcinoma (ESCC).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!